Inhibition and significance of pigment epithelium-derived factor in the development and metastasis of prostate cancer

National Medical Journal of China

Volumn 90, Issue 42, 2010, Pages 2980-2983

  Guo, Zheng Hui ^a   Huang, Hai ^a   Du, Tao ^a   Xu, Ke Wei ^a   Cao, Yi ^a   Chen, Jie Qing ^a   Dong, Wen ^a   Yao, You Sheng ^a   Lin, Tian Xin ^a   Xie, Wen Lian ^a   Jiang, Chun ^a   Han, Jin Li ^a   Huang, Jian ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Immunohistochemistry; Metastasis; Pigment epithelium derived factor; Prostate neoplasms

Indexed keywords

PIGMENT EPITHELIUM DERIVED FACTOR; EYE PROTEIN; NERVE GROWTH FACTOR; PIGMENT EPITHELIUM-DERIVED FACTOR; SERINE PROTEINASE INHIBITOR;

ARTICLE; CANCER CELL CULTURE; CANCER STAGING; CARCINOGENESIS; CELL STRAIN LNCAP; CONTROLLED STUDY; DISEASE ASSOCIATION; HISTOLOGY; IMMUNOHISTOCHEMISTRY; METASTASIS; PROSTATE CANCER; PROSTATE CARCINOMA; PROTEIN EXPRESSION; WESTERN BLOTTING; ADULT; AGED; CANCER INVASION; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROSTATE TUMOR;

ADULT; AGED; AGED, 80 AND OVER; EYE PROTEINS; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NERVE GROWTH FACTORS; PROSTATIC NEOPLASMS; SERPINS;

EID: 84871454702     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2010.42.009     Document Type: Article

References (12)

1. Tombran-Tink J, Chader G G, Johnson L V. PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity. Exp Eye Res, 1991, 53:411-414.
2. Tombran-Tink J, Barnstable C J. Therapeutic prospects for PEDF: more than a promising angiogenesis inhibitor. Trends Mol Med, 2003, 9:244-250.
3. Guan M, Pang G P, Yam H F. Inhibition of glioma invasion by overexpression of pigment epithelium-derived factor. Cancer Gene Ther, 2004, 11:325-332.
4. Quan G M, Choong P F. Anti-angiogenic therapy for osteosarcoma. Cancer Metastasis Rev, 2006, 25:707-713.
5. Abramson L P, Browne M, Stellmach V. Pigment epithelium-derived factor targets endothelial and epithelial cells in Wilms' tumor. J Pediatr Surg, 2006, 41:1351-1356.
6. Abe R, Shimizu T, Yamagishi S H. Overexpression of pigment epithelium-derived factor decreases angiogenesis and inhibits the growth of human malignant melanoma cells in vivo. Am J Pathol, 2004, 164:1225-1232.
7. Doll J A, Sterllmach V M, Bouck N P, et al. Pigment epithelium-derived factor regulates the vasculature and mass of the prostate and pancreas. Nature medicine, 2003, 9:774-780.
8. Mirochnik Y, Aurora A, Schulze-Hoepfner F T, et al. Short pigment epithelial-derived factor-derived peptide inhibits angiogenesis and tumor growth. Clin Cancer Res, 2009, 15: 1655-1663.
9. Fernandez-Garcia N I, Volpert O V, Jimenez B. Pigment epithelium-derived factor as a multifunctional antitumor factor. J Mol Med, 2007, 85:15-22.
10. Tong J P, Lam D S, Chan W M. Effects of triamcinolone on the expression of VEGF and PEDF in human retinal pigment epithelial and human umbilical vein endothelial cells. Mol Vis, 2006, 12: 1490-1495.
11. Zamiri P, Sugita S, Streilein J W. Immunosuppressive properties of the pigmented epithelial cells and the subretinal space. Chem Immunol Allergy, 2007, 92:86-93.
12. Ek E T, Dass C R, Choong P F. PEDF: a potential molecular therapeutic target with multiple anti-cancer activities. Trends Mol Med, 2006, 12:497-502.